DK0769293T3 - Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist - Google Patents

Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist

Info

Publication number
DK0769293T3
DK0769293T3 DK96402098T DK96402098T DK0769293T3 DK 0769293 T3 DK0769293 T3 DK 0769293T3 DK 96402098 T DK96402098 T DK 96402098T DK 96402098 T DK96402098 T DK 96402098T DK 0769293 T3 DK0769293 T3 DK 0769293T3
Authority
DK
Denmark
Prior art keywords
antagonist
beta
substance
adrenergic agonist
adrenergic
Prior art date
Application number
DK96402098T
Other languages
Danish (da)
English (en)
Inventor
Lacharriere Olivier De
Lionel Breton
Jacques Leclaire
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of DK0769293T3 publication Critical patent/DK0769293T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK96402098T 1995-10-23 1996-10-01 Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist DK0769293T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512447A FR2740040B1 (fr) 1995-10-23 1995-10-23 Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p

Publications (1)

Publication Number Publication Date
DK0769293T3 true DK0769293T3 (da) 1999-12-06

Family

ID=9483809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96402098T DK0769293T3 (da) 1995-10-23 1996-10-01 Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist

Country Status (14)

Country Link
US (2) US5958432A (pt)
EP (1) EP0769293B1 (pt)
JP (1) JP3636473B2 (pt)
AR (1) AR004052A1 (pt)
BR (1) BR9611302A (pt)
CA (1) CA2222311C (pt)
DE (1) DE69603681T2 (pt)
DK (1) DK0769293T3 (pt)
FR (1) FR2740040B1 (pt)
HU (1) HUP9900511A3 (pt)
NO (1) NO312273B1 (pt)
PL (1) PL186366B1 (pt)
RU (1) RU2169552C2 (pt)
WO (1) WO1997015281A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948972A (en) * 1994-12-22 1999-09-07 Kla-Tencor Corporation Dual stage instrument for scanning a specimen
AU2001282988B2 (en) 2000-07-26 2006-01-05 Atopic Pty Ltd Methods for treating atopic disorders
ITPD20010187A1 (it) * 2001-07-23 2003-01-23 Cutech Srl Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
EP1295599A1 (en) * 2001-09-21 2003-03-26 Boehringer Ingelheim International GmbH Method for the treatment of prevention of atopic dermatitis
US20030219573A1 (en) * 2002-03-27 2003-11-27 Torgny Falk Absorbent product
US8343519B2 (en) * 2003-02-19 2013-01-01 L'oreal S.A. Chemical enhancer and method
EP1613266A4 (en) * 2003-04-15 2009-05-06 Theraquest Biosciences Llc METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
EP1813285A4 (en) * 2004-11-19 2010-06-09 Kissei Pharmaceutical PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST NEUROPATHIC PAIN
MY147864A (en) 2005-04-13 2013-01-31 Astion Dev As Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
EP2252278B1 (fr) * 2008-01-18 2011-10-26 Centre National de la Recherche Scientifique - CNRS Agonistes béta-2 adrénergiques pour utilisation dans le traitement de l'allodynie neuropathique chronique
GB0805535D0 (en) * 2008-03-27 2008-04-30 Univ Leicester Scar prevention
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
JP5425229B2 (ja) * 2009-02-24 2014-02-26 ノバルティス アーゲー Ｎｋ受容体アンタゴニストの使用
GB2513297A (en) 2013-03-08 2014-10-29 Univ Leicester Methods
EP3319607A4 (en) 2015-07-09 2019-04-03 Galderma S.A. METHOD FOR REDUCING HAIR LOSS IN CONNECTION WITH CHEMOTHERAPY
WO2019230230A1 (ja) * 2018-05-29 2019-12-05 株式会社ナノエッグ アトピー性皮膚炎を治療または予防するための組成物
AU2019336248A1 (en) * 2018-09-08 2021-05-13 Tan WEN New use of R-enantiomer of adrenergic β2 receptor agonists for treatment of inflammatory bowel disease and its extra intestinal manifestations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5366731A (en) * 1990-08-24 1994-11-22 Wisconsin Alumni Research Foundation Cosmetic compositions containing secosterol compounds
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JPH07258067A (ja) * 1994-03-18 1995-10-09 Kao Corp 浴用剤組成物
FR2719474B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.

Also Published As

Publication number Publication date
WO1997015281A1 (fr) 1997-05-01
NO976143L (no) 1998-06-03
JP2000503628A (ja) 2000-03-28
JP3636473B2 (ja) 2005-04-06
BR9611302A (pt) 1999-03-30
EP0769293A3 (fr) 1997-05-02
DE69603681T2 (de) 1999-11-25
NO976143D0 (no) 1997-12-30
EP0769293B1 (fr) 1999-08-11
AR004052A1 (es) 1998-09-30
NO312273B1 (no) 2002-04-22
FR2740040B1 (fr) 1997-12-05
US5958432A (en) 1999-09-28
FR2740040A1 (fr) 1997-04-25
PL324924A1 (en) 1998-06-22
MX9710475A (es) 1998-08-30
DE69603681D1 (de) 1999-09-16
CA2222311A1 (fr) 1997-05-01
HUP9900511A2 (hu) 1999-07-28
US6267972B1 (en) 2001-07-31
CA2222311C (fr) 2006-11-28
EP0769293A2 (fr) 1997-04-23
PL186366B1 (pl) 2003-12-31
RU2169552C2 (ru) 2001-06-27
HUP9900511A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
DK0769293T3 (da) Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist
DK1019077T4 (da) Hidtil ukendte exendinagonistforbindelser
NO960081D0 (no) Östrogen-agonist/antagonister
NO964871D0 (no) Nye agonistforbindelser
ID24836A (id) Agonis prostaglandin
DK0722736T3 (da) Topisk sammensætning indeholdende en antagonist for substans P
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
DE69800895D1 (de) Interleukin-1 Rezeptor Antagonist beta (il-1rabeta)
EE04141B1 (et) 5-HT tagasihaarde inhibiitori kombinatsioon h5-HT1B antagonisti või osalise agonistiga
PT1036072E (pt) Antagonistas de receptores de trombina
BR9505382A (pt) Utilização de ao menos um antagonista de substáncia P
NO20004668D0 (no) 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister
MA26890A1 (fr) Metabolites agonistes/ antagonistes d'oestrogenes
DK0696194T3 (da) Anvendelse af indolderivater som 5HT1-antagonister
DK0854867T3 (da) Tetrahydroquinoliner som NMDA-antagonister
BR9608594A (pt) Composições para o combate de protozoários parasíticos
ID26086A (id) Ligan-ligan reseptor 5ht1 azabisiklik
IS4597A (is) Ný lyfjafræðileg notkun AII-viðtaka mótlyfja
BR9505392A (pt) Utilizações de ao menos um antagonista de substância P
DE69911964D1 (de) Leistungsmessung von fernmeldesystemen
FI943359A0 (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
DK0944601T3 (da) Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
DK0786002T3 (da) Intracellulær isoform af interleukin-1-receptorantagonisten
SE9803428D0 (sv) Blocking of alfa2beta1-receptors